Abstract

BackgroundDengue was regarded as a mild epidemic in mainland China transmitted by Aedes albopictus. However, the 2014 record-breaking outbreak in Guangzhou could change the situation. In order to provide an early warning of epidemic trends and provide evidence for prevention and control strategies, we seek to characterize the 2014 outbreak through application of detailed cases and entomological data, as well as phylogenetic analysis of viral envelope (E) gene.MethodsWe used case survey data identified through the Notifiable Infectious Disease Report System, entomological surveillance and population serosurvey, along with laboratory testing for IgM/IgG, NS1, and isolation of viral samples followed by E gene sequencing and phylogenetic analysis to examine the epidemiological and molecular characteristics of the outbreak.ResultsThe 2014 dengue outbreak in Guangzhou accounted for nearly 80% of total reported cases that year in mainland China; a total of 37,376 cases including 37,340 indigenous cases with incidence rate 2908.3 per million and 36 imported cases were reported in Guangzhou, with 14,055 hospitalized and 5 deaths. The epidemic lasted for 193 days from June 11 to December 21, with the highest incidence observed in domestic workers, the unemployed and retirees. The inapparent infection rate was 18.00% (135/750). In total, 96 dengue virus 1 (DENV-1) and 11 dengue virus 2 (DENV-2) strains were isolated. Phylogenetic analysis indicated that the DENV-1 strains were divided into genotype I and V, similar to the strains isolated in Guangzhou and Dongguan in 2013. The DENV-2 strains isolated were similar to those imported from Thailand on May 11 in 2014 and that imported from Indonesia in 2012.ConclusionsThe 2014 dengue epidemic was confirmed to be the first co-circulation of DENV-1 and DENV-2 in Guangzhou. The DENV-1 strain was endemic, while the DENV-2 strain was imported, being efficiently transmitted by the Aedes albopictus vector species at levels as high as Aedes aegypti.

Highlights

  • Dengue was regarded as a mild epidemic in mainland China transmitted by Aedes albopictus

  • Dengue is a mosquito-borne viral infection that can produce a wide spectrum of symptoms, from a mild febrile illness progressing to dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS)

  • Patients identified from passive surveillance after seeking medical attention or from active case surveillance conducted by the Center for Disease Control and Prevention (CDC) after initial dengue transmission occurs should be reported to the Notifiable Infectious Disease Reporting System (NIDRS) within 24 h

Read more

Summary

Introduction

Dengue was regarded as a mild epidemic in mainland China transmitted by Aedes albopictus. Over the past 50 years, dengue has affected more than 100 countries in tropical and subtropical areas accompanying a 30-fold increase in global incidence [1]. The incidence and disease burden are increasing dramatically due to human population growth, spread of mosquito vectors, globalization, urbanization, and climate change [2, 3]. The dengue virus (DENV) is a member of the genus Flavivirus family Flaviviridae, and is a single-stranded positive-sense, RNA virus with a genome of about 11 kb. It is antigenically divided into four serotypes (DENV-1, DENV-2, DENV-3, and DENV-4). There are still factors contributing to the challenge of vaccine development, such as viral interference, reversion to virulence, antibody-dependent enhancement (ADE) and the lack of immunologic correlates and good animal models [6]

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.